ciprofibrate has been researched along with Argentaffinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spencer, AJ | 2 |
| Barbolt, TA | 1 |
| Henry, DC | 1 |
| Eason, CT | 2 |
| Sauerschell, RJ | 1 |
| Bonner, FW | 2 |
| Pattison, A | 1 |
| Howells, DD | 1 |
2 other studies available for ciprofibrate and Argentaffinoma
| Article | Year |
|---|---|
Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate.
Topics: Animals; Callitrichinae; Carcinoid Tumor; Clofibrate; Clofibric Acid; Fibric Acids; Gastric Mucosa; | 1989 |
Assessment of gastric antisecretory effects of phenoxyisobutyrate derivatives in the rat and the mouse.
Topics: Administration, Oral; Animals; Bezafibrate; Carcinoid Tumor; Clofibrate; Clofibric Acid; Fibric Acid | 1988 |